DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Acotiamide is an investigational drug.
There have been 4 clinical trials for Acotiamide. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2014.
The most common disease conditions in clinical trials are Dyspepsia, Gastritis, and [disabled in preview]. The leading clinical trial sponsors are Astellas Pharma Inc, Universitaire Ziekenhuizen Leuven, and Zeria Pharmaceutical.
Recent Clinical Trials for Acotiamide
|Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers||Universitaire Ziekenhuizen Leuven||N/A|
|Phase III, Long-term, Open-label Safety Study of Z-338||Zeria Pharmaceutical||Phase 3|
|A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults||Astellas Pharma Inc||Phase 1|